Concepts (293)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Diabetes Mellitus, Type 2 | 10 | 2025 | 689 | 2.940 |
Why?
|
| Obesity | 15 | 2018 | 821 | 2.720 |
Why?
|
| African Americans | 11 | 2019 | 429 | 1.820 |
Why?
|
| Social Determinants of Health | 2 | 2024 | 39 | 1.590 |
Why?
|
| Weight Loss | 13 | 2022 | 298 | 1.540 |
Why?
|
| Dietary Approaches To Stop Hypertension | 3 | 2026 | 8 | 1.430 |
Why?
|
| Humans | 58 | 2026 | 17622 | 1.370 |
Why?
|
| Diabetes Mellitus | 6 | 2023 | 452 | 1.320 |
Why?
|
| Blood Pressure | 4 | 2026 | 288 | 1.290 |
Why?
|
| Self Care | 6 | 2017 | 144 | 1.260 |
Why?
|
| Hypertension | 5 | 2026 | 486 | 1.230 |
Why?
|
| Weight Reduction Programs | 4 | 2018 | 51 | 1.220 |
Why?
|
| Overweight | 4 | 2019 | 266 | 1.120 |
Why?
|
| Behavior Therapy | 5 | 2018 | 125 | 1.110 |
Why?
|
| Delivery of Health Care, Integrated | 3 | 2022 | 540 | 1.060 |
Why?
|
| Patient Education as Topic | 4 | 2017 | 193 | 1.050 |
Why?
|
| Female | 36 | 2026 | 12715 | 0.960 |
Why?
|
| Self-Management | 2 | 2025 | 27 | 0.940 |
Why?
|
| Health Behavior | 7 | 2022 | 348 | 0.890 |
Why?
|
| Life Style | 4 | 2018 | 321 | 0.880 |
Why?
|
| Male | 30 | 2026 | 10014 | 0.850 |
Why?
|
| Adult | 24 | 2026 | 7621 | 0.840 |
Why?
|
| Racism | 1 | 2024 | 22 | 0.820 |
Why?
|
| Prenatal Care | 1 | 2025 | 129 | 0.800 |
Why?
|
| Health Equity | 1 | 2023 | 27 | 0.740 |
Why?
|
| Pregnancy Complications | 1 | 2025 | 208 | 0.730 |
Why?
|
| Primary Health Care | 3 | 2017 | 729 | 0.730 |
Why?
|
| Prediabetic State | 2 | 2021 | 62 | 0.690 |
Why?
|
| Middle Aged | 20 | 2026 | 7954 | 0.670 |
Why?
|
| Blood Glucose | 1 | 2023 | 319 | 0.670 |
Why?
|
| Referral and Consultation | 2 | 2017 | 161 | 0.590 |
Why?
|
| Decision Making | 3 | 2016 | 177 | 0.560 |
Why?
|
| Feeding Behavior | 3 | 2014 | 163 | 0.550 |
Why?
|
| Glycated Hemoglobin A | 5 | 2022 | 179 | 0.550 |
Why?
|
| Centers for Medicare and Medicaid Services (U.S.) | 1 | 2017 | 4 | 0.530 |
Why?
|
| Behavioral Medicine | 1 | 2017 | 4 | 0.520 |
Why?
|
| Obesity Management | 1 | 2017 | 4 | 0.510 |
Why?
|
| Societies, Medical | 1 | 2017 | 71 | 0.510 |
Why?
|
| Metabolic Syndrome | 2 | 2018 | 64 | 0.510 |
Why?
|
| Aged | 11 | 2026 | 6223 | 0.510 |
Why?
|
| Social Isolation | 2 | 2025 | 20 | 0.500 |
Why?
|
| Surveys and Questionnaires | 8 | 2025 | 1296 | 0.490 |
Why?
|
| Physicians | 1 | 2017 | 120 | 0.490 |
Why?
|
| Psychometrics | 3 | 2014 | 119 | 0.470 |
Why?
|
| Research Design | 2 | 2021 | 337 | 0.460 |
Why?
|
| Autonomic Nervous System | 1 | 2015 | 3 | 0.450 |
Why?
|
| Exercise | 6 | 2025 | 538 | 0.450 |
Why?
|
| Heart Rate | 1 | 2015 | 36 | 0.450 |
Why?
|
| Asthma | 3 | 2011 | 401 | 0.440 |
Why?
|
| Emigrants and Immigrants | 1 | 2015 | 27 | 0.440 |
Why?
|
| Problem Solving | 1 | 2014 | 8 | 0.440 |
Why?
|
| Diet, Sodium-Restricted | 2 | 2026 | 23 | 0.430 |
Why?
|
| Lost to Follow-Up | 1 | 2014 | 2 | 0.410 |
Why?
|
| Boston | 4 | 2026 | 31 | 0.410 |
Why?
|
| Stress, Psychological | 1 | 2015 | 141 | 0.400 |
Why?
|
| Electronic Health Records | 2 | 2019 | 719 | 0.390 |
Why?
|
| Body Mass Index | 9 | 2026 | 959 | 0.380 |
Why?
|
| Models, Statistical | 1 | 2013 | 171 | 0.370 |
Why?
|
| Psychosomatic Medicine | 1 | 2012 | 1 | 0.360 |
Why?
|
| Chronic Disease | 1 | 2014 | 398 | 0.360 |
Why?
|
| Models, Psychological | 1 | 2012 | 21 | 0.360 |
Why?
|
| Immunoglobulin E | 1 | 2011 | 5 | 0.350 |
Why?
|
| Medicare | 3 | 2025 | 197 | 0.330 |
Why?
|
| Treatment Outcome | 9 | 2026 | 1161 | 0.330 |
Why?
|
| Telemedicine | 2 | 2025 | 196 | 0.310 |
Why?
|
| Cholesterol, LDL | 2 | 2026 | 117 | 0.280 |
Why?
|
| Gastric Bypass | 2 | 2022 | 70 | 0.270 |
Why?
|
| Fruit | 3 | 2023 | 79 | 0.260 |
Why?
|
| Young Adult | 5 | 2024 | 2538 | 0.260 |
Why?
|
| European Continental Ancestry Group | 5 | 2019 | 470 | 0.260 |
Why?
|
| United States | 6 | 2025 | 3922 | 0.260 |
Why?
|
| Randomized Controlled Trials as Topic | 2 | 2025 | 323 | 0.250 |
Why?
|
| Obesity, Morbid | 2 | 2022 | 121 | 0.250 |
Why?
|
| Annexin A2 | 3 | 2001 | 3 | 0.240 |
Why?
|
| Follow-Up Studies | 3 | 2017 | 1157 | 0.230 |
Why?
|
| Fibrinolysin | 4 | 2001 | 4 | 0.220 |
Why?
|
| Minority Groups | 2 | 2023 | 104 | 0.220 |
Why?
|
| Budesonide | 2 | 2001 | 2 | 0.220 |
Why?
|
| Needs Assessment | 1 | 2025 | 66 | 0.220 |
Why?
|
| Adolescent | 8 | 2022 | 3625 | 0.220 |
Why?
|
| Spatial Analysis | 1 | 2024 | 11 | 0.220 |
Why?
|
| Pragmatic Clinical Trials as Topic | 1 | 2025 | 65 | 0.210 |
Why?
|
| Pre-Eclampsia | 1 | 2025 | 41 | 0.210 |
Why?
|
| Community Networks | 1 | 2024 | 21 | 0.210 |
Why?
|
| Vegetables | 2 | 2019 | 88 | 0.210 |
Why?
|
| Body Weight | 4 | 2018 | 203 | 0.210 |
Why?
|
| Emotions | 1 | 2024 | 34 | 0.210 |
Why?
|
| Gender Identity | 1 | 2024 | 37 | 0.210 |
Why?
|
| Health Promotion | 2 | 2023 | 293 | 0.210 |
Why?
|
| Precision Medicine | 1 | 2023 | 31 | 0.200 |
Why?
|
| Health Status | 2 | 2023 | 291 | 0.190 |
Why?
|
| Program Evaluation | 2 | 2016 | 214 | 0.190 |
Why?
|
| Cocaine | 1 | 2023 | 7 | 0.190 |
Why?
|
| Stress Disorders, Post-Traumatic | 1 | 2023 | 73 | 0.180 |
Why?
|
| Bronchodilator Agents | 1 | 2001 | 22 | 0.180 |
Why?
|
| Pilot Projects | 1 | 2022 | 214 | 0.180 |
Why?
|
| Fibroma | 1 | 2021 | 2 | 0.170 |
Why?
|
| Gingival Neoplasms | 1 | 2021 | 2 | 0.170 |
Why?
|
| Residence Characteristics | 1 | 2023 | 256 | 0.170 |
Why?
|
| Cannabis | 1 | 2023 | 83 | 0.170 |
Why?
|
| Bariatric Surgery | 1 | 2022 | 133 | 0.160 |
Why?
|
| Counseling | 2 | 2026 | 173 | 0.150 |
Why?
|
| Quality of Life | 2 | 2014 | 505 | 0.150 |
Why?
|
| Opioid-Related Disorders | 1 | 2023 | 185 | 0.150 |
Why?
|
| Pregnancy | 1 | 2025 | 1565 | 0.150 |
Why?
|
| Phentermine | 1 | 2019 | 10 | 0.150 |
Why?
|
| Evidence-Based Medicine | 2 | 2023 | 173 | 0.150 |
Why?
|
| Appetite Depressants | 1 | 2019 | 15 | 0.150 |
Why?
|
| Risk Factors | 3 | 2016 | 3291 | 0.150 |
Why?
|
| Mental Health Services | 1 | 2021 | 155 | 0.150 |
Why?
|
| Stair Climbing | 1 | 2019 | 1 | 0.150 |
Why?
|
| Healthy Aging | 1 | 2019 | 11 | 0.140 |
Why?
|
| Urban Population | 2 | 2016 | 111 | 0.140 |
Why?
|
| Social Support | 2 | 2018 | 215 | 0.140 |
Why?
|
| Diet Therapy | 1 | 2018 | 9 | 0.140 |
Why?
|
| Choice Behavior | 2 | 2016 | 45 | 0.140 |
Why?
|
| Substance-Related Disorders | 1 | 2023 | 417 | 0.140 |
Why?
|
| Health Knowledge, Attitudes, Practice | 2 | 2025 | 368 | 0.140 |
Why?
|
| Self Report | 2 | 2023 | 262 | 0.140 |
Why?
|
| Health Status Disparities | 1 | 2019 | 151 | 0.140 |
Why?
|
| Exercise Therapy | 1 | 2018 | 75 | 0.130 |
Why?
|
| Women's Health | 1 | 2019 | 198 | 0.130 |
Why?
|
| Mentoring | 1 | 2017 | 29 | 0.130 |
Why?
|
| Interviews as Topic | 1 | 2017 | 324 | 0.130 |
Why?
|
| Socioeconomic Factors | 3 | 2014 | 603 | 0.120 |
Why?
|
| Ethnic Groups | 1 | 2019 | 443 | 0.120 |
Why?
|
| Insurance Coverage | 1 | 2017 | 99 | 0.120 |
Why?
|
| Plasminogen | 3 | 2001 | 3 | 0.120 |
Why?
|
| Health Personnel | 1 | 2017 | 135 | 0.120 |
Why?
|
| Cohort Studies | 5 | 2022 | 2502 | 0.120 |
Why?
|
| Child | 5 | 2014 | 2485 | 0.120 |
Why?
|
| Severity of Illness Index | 2 | 2011 | 446 | 0.120 |
Why?
|
| Qualitative Research | 1 | 2017 | 290 | 0.120 |
Why?
|
| Practice Guidelines as Topic | 1 | 2017 | 319 | 0.110 |
Why?
|
| Respiratory Rate | 1 | 2015 | 1 | 0.110 |
Why?
|
| Goals | 1 | 2015 | 28 | 0.110 |
Why?
|
| Emigration and Immigration | 1 | 2015 | 15 | 0.110 |
Why?
|
| Tissue and Organ Procurement | 1 | 2014 | 3 | 0.110 |
Why?
|
| Tissue Donors | 1 | 2014 | 7 | 0.110 |
Why?
|
| Patient Compliance | 2 | 2014 | 269 | 0.110 |
Why?
|
| Patient Care Team | 1 | 2015 | 107 | 0.110 |
Why?
|
| Neuropsychological Tests | 1 | 2014 | 48 | 0.110 |
Why?
|
| Video Recording | 1 | 2014 | 15 | 0.110 |
Why?
|
| Reproducibility of Results | 2 | 2013 | 363 | 0.110 |
Why?
|
| Kidney Transplantation | 1 | 2014 | 28 | 0.110 |
Why?
|
| Bulimia | 1 | 2014 | 8 | 0.100 |
Why?
|
| Energy Metabolism | 1 | 2013 | 48 | 0.100 |
Why?
|
| Community-Based Participatory Research | 1 | 2014 | 46 | 0.100 |
Why?
|
| Nebulizers and Vaporizers | 2 | 2011 | 9 | 0.100 |
Why?
|
| Diet | 1 | 2015 | 355 | 0.100 |
Why?
|
| African Continental Ancestry Group | 1 | 2013 | 140 | 0.100 |
Why?
|
| Kidney Failure, Chronic | 1 | 2014 | 149 | 0.100 |
Why?
|
| Binge-Eating Disorder | 1 | 2013 | 13 | 0.100 |
Why?
|
| Pediatric Obesity | 1 | 2014 | 101 | 0.100 |
Why?
|
| Nutrition Surveys | 1 | 2012 | 55 | 0.090 |
Why?
|
| Culture | 2 | 2009 | 30 | 0.090 |
Why?
|
| Patient Participation | 1 | 2013 | 124 | 0.090 |
Why?
|
| Multivariate Analysis | 1 | 2014 | 527 | 0.090 |
Why?
|
| Motor Activity | 1 | 2014 | 207 | 0.090 |
Why?
|
| Neutrophils | 1 | 2011 | 2 | 0.090 |
Why?
|
| New York City | 1 | 2011 | 24 | 0.090 |
Why?
|
| Peak Expiratory Flow Rate | 1 | 2011 | 13 | 0.090 |
Why?
|
| Proportional Hazards Models | 1 | 2014 | 702 | 0.090 |
Why?
|
| Leukocyte Count | 1 | 2011 | 24 | 0.090 |
Why?
|
| Data Interpretation, Statistical | 1 | 2012 | 69 | 0.090 |
Why?
|
| Family Characteristics | 2 | 2014 | 70 | 0.090 |
Why?
|
| Patient Selection | 1 | 2013 | 181 | 0.090 |
Why?
|
| Forced Expiratory Volume | 1 | 2011 | 66 | 0.090 |
Why?
|
| Cities | 1 | 2011 | 30 | 0.090 |
Why?
|
| Administration, Oral | 1 | 2011 | 84 | 0.090 |
Why?
|
| Cardiovascular Diseases | 1 | 2016 | 545 | 0.090 |
Why?
|
| Adrenal Cortex Hormones | 1 | 2011 | 67 | 0.090 |
Why?
|
| Sensitivity and Specificity | 1 | 2012 | 302 | 0.080 |
Why?
|
| Anti-Asthmatic Agents | 1 | 2011 | 88 | 0.080 |
Why?
|
| Dose-Response Relationship, Drug | 2 | 2001 | 122 | 0.080 |
Why?
|
| Disease Progression | 1 | 2011 | 266 | 0.080 |
Why?
|
| Nutritive Value | 1 | 2009 | 11 | 0.080 |
Why?
|
| Perception | 1 | 2009 | 56 | 0.080 |
Why?
|
| Tissue Plasminogen Activator | 2 | 2000 | 25 | 0.070 |
Why?
|
| Veterans | 1 | 2010 | 149 | 0.070 |
Why?
|
| Hispanic Americans | 1 | 2011 | 370 | 0.070 |
Why?
|
| Aged, 80 and over | 2 | 2025 | 1976 | 0.070 |
Why?
|
| Animals | 4 | 2001 | 285 | 0.060 |
Why?
|
| Chicago | 2 | 2019 | 25 | 0.060 |
Why?
|
| Urban Health | 1 | 2006 | 36 | 0.060 |
Why?
|
| Food Preferences | 1 | 2006 | 23 | 0.060 |
Why?
|
| Costs and Cost Analysis | 1 | 2006 | 65 | 0.060 |
Why?
|
| Nutritionists | 1 | 2026 | 1 | 0.060 |
Why?
|
| Retrospective Studies | 3 | 2022 | 2502 | 0.060 |
Why?
|
| Blood Pressure Determination | 1 | 2026 | 56 | 0.060 |
Why?
|
| Administration, Inhalation | 2 | 2001 | 39 | 0.050 |
Why?
|
| Double-Blind Method | 2 | 2001 | 144 | 0.050 |
Why?
|
| Consensus | 1 | 2023 | 41 | 0.050 |
Why?
|
| Social Justice | 1 | 2023 | 8 | 0.050 |
Why?
|
| Cattle | 2 | 2001 | 10 | 0.050 |
Why?
|
| Prevalence | 2 | 2019 | 830 | 0.050 |
Why?
|
| Enzyme Activation | 2 | 2000 | 8 | 0.050 |
Why?
|
| Hypnotics and Sedatives | 1 | 2023 | 14 | 0.050 |
Why?
|
| Substance Abuse Detection | 1 | 2023 | 17 | 0.050 |
Why?
|
| Cell Membrane | 2 | 2000 | 6 | 0.050 |
Why?
|
| Gastrectomy | 1 | 2022 | 46 | 0.050 |
Why?
|
| Recurrence | 1 | 2022 | 166 | 0.050 |
Why?
|
| Internet | 2 | 2014 | 207 | 0.050 |
Why?
|
| Infant Welfare | 1 | 2001 | 4 | 0.040 |
Why?
|
| Time | 1 | 2001 | 20 | 0.040 |
Why?
|
| Angiogenesis Inhibitors | 1 | 2001 | 6 | 0.040 |
Why?
|
| Peptide Fragments | 1 | 2001 | 28 | 0.040 |
Why?
|
| Withholding Treatment | 1 | 2001 | 26 | 0.040 |
Why?
|
| Cost-Benefit Analysis | 1 | 2022 | 237 | 0.040 |
Why?
|
| Child Welfare | 1 | 2001 | 40 | 0.040 |
Why?
|
| Emergency Service, Hospital | 1 | 2025 | 402 | 0.040 |
Why?
|
| Depression | 2 | 2018 | 507 | 0.040 |
Why?
|
| Fibrin | 1 | 2001 | 1 | 0.040 |
Why?
|
| Fibrinolysis | 1 | 2001 | 2 | 0.040 |
Why?
|
| Infant | 2 | 2001 | 1228 | 0.040 |
Why?
|
| Masks | 1 | 2000 | 5 | 0.040 |
Why?
|
| Anti-Inflammatory Agents | 1 | 2000 | 27 | 0.040 |
Why?
|
| Hydrolysis | 1 | 2000 | 1 | 0.040 |
Why?
|
| Substrate Specificity | 1 | 2000 | 1 | 0.040 |
Why?
|
| Enzyme Inhibitors | 1 | 2000 | 4 | 0.040 |
Why?
|
| Cell Line | 1 | 2000 | 11 | 0.040 |
Why?
|
| Membrane Proteins | 1 | 2000 | 39 | 0.040 |
Why?
|
| Kidney | 1 | 2000 | 52 | 0.040 |
Why?
|
| Analgesics, Opioid | 1 | 2023 | 258 | 0.040 |
Why?
|
| Hospitalization | 1 | 2025 | 831 | 0.040 |
Why?
|
| Receptors, Cell Surface | 1 | 1998 | 6 | 0.040 |
Why?
|
| Michigan | 1 | 2019 | 27 | 0.040 |
Why?
|
| Osteoarthritis | 1 | 2019 | 15 | 0.040 |
Why?
|
| Time Factors | 1 | 2001 | 1038 | 0.040 |
Why?
|
| Alabama | 2 | 2009 | 23 | 0.040 |
Why?
|
| Child, Preschool | 1 | 2001 | 1455 | 0.030 |
Why?
|
| Depressive Disorder | 1 | 2018 | 186 | 0.030 |
Why?
|
| Longitudinal Studies | 1 | 2019 | 686 | 0.030 |
Why?
|
| Kidney Tubules, Proximal | 1 | 1996 | 1 | 0.030 |
Why?
|
| Oxidants | 1 | 1996 | 2 | 0.030 |
Why?
|
| Lipid Peroxidation | 1 | 1996 | 4 | 0.030 |
Why?
|
| Fatty Acids, Unsaturated | 1 | 1996 | 5 | 0.030 |
Why?
|
| Hydrogen Peroxide | 1 | 1996 | 2 | 0.030 |
Why?
|
| Television | 1 | 2014 | 16 | 0.030 |
Why?
|
| Adolescent Health Services | 1 | 2014 | 40 | 0.030 |
Why?
|
| Sleep | 1 | 2014 | 56 | 0.030 |
Why?
|
| Health Education | 1 | 2014 | 82 | 0.030 |
Why?
|
| Child Health Services | 1 | 2014 | 107 | 0.030 |
Why?
|
| Personality Inventory | 1 | 2013 | 12 | 0.020 |
Why?
|
| False Positive Reactions | 1 | 2013 | 26 | 0.020 |
Why?
|
| Sleep Wake Disorders | 1 | 2013 | 33 | 0.020 |
Why?
|
| Patient-Centered Care | 1 | 2014 | 190 | 0.020 |
Why?
|
| Predictive Value of Tests | 1 | 2013 | 346 | 0.020 |
Why?
|
| Comorbidity | 1 | 2013 | 552 | 0.020 |
Why?
|
| Nutritional Status | 1 | 2010 | 32 | 0.020 |
Why?
|
| Program Development | 1 | 2010 | 65 | 0.020 |
Why?
|
| Cooking | 1 | 2009 | 17 | 0.020 |
Why?
|
| Evaluation Studies as Topic | 1 | 2009 | 28 | 0.020 |
Why?
|
| Mice, Inbred C57BL | 2 | 2001 | 20 | 0.020 |
Why?
|
| Mice | 2 | 2001 | 82 | 0.020 |
Why?
|
| Sex Factors | 1 | 2011 | 599 | 0.020 |
Why?
|
| Age Factors | 1 | 2011 | 874 | 0.020 |
Why?
|
| Cells, Cultured | 2 | 1998 | 14 | 0.020 |
Why?
|
| School Health Services | 1 | 2006 | 40 | 0.020 |
Why?
|
| Focus Groups | 1 | 2007 | 144 | 0.020 |
Why?
|
| Allantois | 1 | 2001 | 1 | 0.010 |
Why?
|
| Circular Dichroism | 1 | 2001 | 1 | 0.010 |
Why?
|
| Kringles | 1 | 2001 | 1 | 0.010 |
Why?
|
| Carcinoma, Lewis Lung | 1 | 2001 | 1 | 0.010 |
Why?
|
| In Vitro Techniques | 1 | 2001 | 6 | 0.010 |
Why?
|
| Blotting, Western | 1 | 2001 | 3 | 0.010 |
Why?
|
| Electrophoresis, Polyacrylamide Gel | 1 | 2001 | 5 | 0.010 |
Why?
|
| Chick Embryo | 1 | 2001 | 2 | 0.010 |
Why?
|
| Mass Spectrometry | 1 | 2001 | 6 | 0.010 |
Why?
|
| Neovascularization, Pathologic | 1 | 2001 | 3 | 0.010 |
Why?
|
| Amino Acid Sequence | 1 | 2001 | 12 | 0.010 |
Why?
|
| Endothelium, Vascular | 1 | 2001 | 5 | 0.010 |
Why?
|
| Molecular Sequence Data | 1 | 2001 | 17 | 0.010 |
Why?
|
| Protein Conformation | 1 | 2001 | 2 | 0.010 |
Why?
|
| Kinetics | 1 | 2001 | 12 | 0.010 |
Why?
|
| Glycerol | 1 | 2001 | 5 | 0.010 |
Why?
|
| Immunohistochemistry | 1 | 2001 | 45 | 0.010 |
Why?
|
| Lung | 1 | 2001 | 57 | 0.010 |
Why?
|
| Suspensions | 1 | 2000 | 1 | 0.010 |
Why?
|
| Administration, Topical | 1 | 2000 | 5 | 0.010 |
Why?
|
| Glucocorticoids | 1 | 2000 | 23 | 0.010 |
Why?
|
| Drug Administration Schedule | 1 | 2000 | 99 | 0.010 |
Why?
|
| alpha-2-Antiplasmin | 1 | 1998 | 1 | 0.010 |
Why?
|
| Aminocaproic Acid | 1 | 1998 | 1 | 0.010 |
Why?
|
| Sequence Deletion | 1 | 1998 | 1 | 0.010 |
Why?
|
| Plasminogen Activator Inhibitor 1 | 1 | 1998 | 3 | 0.010 |
Why?
|
| Lysine | 1 | 1998 | 2 | 0.010 |
Why?
|
| Mutagenesis | 1 | 1998 | 5 | 0.010 |
Why?
|
| Recombinant Proteins | 1 | 1998 | 17 | 0.010 |
Why?
|
| Lung Neoplasms | 1 | 2001 | 278 | 0.010 |
Why?
|
| Epithelium | 1 | 1996 | 2 | 0.010 |
Why?
|
| Malondialdehyde | 1 | 1996 | 2 | 0.010 |
Why?
|
| Cell Division | 1 | 1996 | 5 | 0.010 |
Why?
|
Concepts
(293)
Derived automatically from this person's publications.
Explore
_
Co-Authors
(18)
People in Profiles who have published with this person.
Explore
_
Similar People
(60)
People who share similar concepts with this person.
Explore
_
Same Department
People who are also in this person's primary department.
Explore
_
Physical Neighbors
People whose addresses are nearby this person.
_
-->